Tumor News and Research

RSS

$2.8 million awarded to translate research on how cancer cells evolve and compete into patient care

The National Institutes of Health recently awarded Cleveland Clinic's Jacob Scott, M.D., D.Phil., and collaborators $2.8 million to translate research on how cancer cells evolve and compete into patient care.

22 Aug 2023

New prognostic risk signature for kidney renal clear cell carcinoma identified

Announcing a new publication for Acta Materia Medica journal. Cuproptosis is a newly identified specific form of programmed cell death.

22 Aug 2023

New method could make single-cell RNA sequencing more accessible to patients

To improve therapies for cancer and other diseases, researchers strive to identify tissue-specific therapeutic targets and diagnostic biomarkers in every patient.

22 Aug 2023

Less is more: Radiotherapy omission deemed safe for certain breast cancer patients

The risk of breast cancer recurrence after breast-conserving surgery.

22 Aug 2023

Study identifies potential new treatment options for people with endometrial cancer

Researchers at Huntsman Cancer Institute identified potential new treatment options for people with endometrial cancer.

21 Aug 2023

Non-traditional gene fusions in luminal breast cancer: A new target for therapy

A new editorial paper was published in Oncotarget's Volume 14 on June 12, 2023, entitled, "Are cis-spliced fusion proteins pathological in more aggressive luminal breast cancer?"

21 Aug 2023

New microneedles could monitor melanoma therapy response

Patients with melanoma, the most concerning form of skin cancer in which pigment-producing cells start to grow out of control, can benefit from existing immunotherapies, but by far not all of them do.

21 Aug 2023

Anti-estrogenic therapies can suppress growth of ER-negative cancers

Anti-estrogenic therapies can suppress the growth of cancer that does not express estrogen receptors; when combined with immune checkpoint inhibitor therapies, they halt tumor progression in mice models.

21 Aug 2023

COVID-19 associated with increased risk of developing various autoimmune diseases and risk could be attenuated by vaccination

COVID-19 can increase the risk of various autoimmune diseases; however, this risk appears to be mitigated by vaccination against COVID-19.

21 Aug 2023

MedAustron demonstrates safety and efficacy of ion therapy for treating skull based chordomas

The MedAustron Center for Ion Therapy has demonstrated the safety and efficacy of both, proton and carbon ion therapy for the treatment of skull based chordomas, a bone located cancer.

21 Aug 2023

New artificial DNA structures can target and destroy cancer cells

A new study highlights the potential of artificial DNA structures that, when fitted with antibodies, instruct the immune system to specifically target cancerous cells.

18 Aug 2023

Regulation of cytotoxic T-cell differentiation and exhaustion by mTOR signaling

Researchers describe molecular signalling regulated by mTOR among memory and exhausted cytotoxic CD8+ T lymphocytes.

18 Aug 2023

New drug candidate nearly doubles survival for patients with aggressive childhood brain tumors

For the first time, researchers have found a potential drug candidate that improved outcomes for patients with a type of childhood brain tumor for which there are no effective treatments.

17 Aug 2023

Lorazepam linked to shorter progression-free survival in pancreatic cancer patients

Patients with pancreatic cancer who took the benzodiazepine lorazepam (Ativan), commonly prescribed to treat anxiety during cancer treatment, had a shorter progression-free survival than patients who did not, according to results published in Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR).

17 Aug 2023

Immunotherapy combination extends progression-free survival in patients with melanoma

A research team co-led by UCLA investigators has shown that an immunotherapy drug combination can be an effective second-line therapy for patients with an aggressive and deadly type of melanoma that is resistant to the widely used immunotherapy drugs known as PD-1 inhibitors.

17 Aug 2023

New insights into the role of liver progenitor cells in liver cancer initiation

Primary liver cancers ranked as the sixth most commonly diagnosed cancers and the third leading cause of cancer-related death in 2020. Among all primary liver cancers, HCC is the most common cancer, accounting for more than 80% of cases with a 5-year survival rate of less than 10% in Western countries.

17 Aug 2023

Researchers receive DoD grant to target chemotherapy resistance in pancreatic cancer

Researchers with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have been awarded a grant from the U.S. Department of Defense (DoD)'s Congressionally Directed Medical Research Program to target chemotherapy resistance in pancreatic cancer.

17 Aug 2023

Tumor News and Research

$2.8 million awarded to translate research on how cancer cells evolve and compete into patient care

New prognostic risk signature for kidney renal clear cell carcinoma identified

New method could make single-cell RNA sequencing more accessible to patients

Less is more: Radiotherapy omission deemed safe for certain breast cancer patients

Study identifies potential new treatment options for people with endometrial cancer

Non-traditional gene fusions in luminal breast cancer: A new target for therapy

New microneedles could monitor melanoma therapy response

Anti-estrogenic therapies can suppress growth of ER-negative cancers

COVID-19 associated with increased risk of developing various autoimmune diseases and risk could be attenuated by vaccination

MedAustron demonstrates safety and efficacy of ion therapy for treating skull based chordomas

New artificial DNA structures can target and destroy cancer cells

Regulation of cytotoxic T-cell differentiation and exhaustion by mTOR signaling

New drug candidate nearly doubles survival for patients with aggressive childhood brain tumors

Lorazepam linked to shorter progression-free survival in pancreatic cancer patients

Immunotherapy combination extends progression-free survival in patients with melanoma

New insights into the role of liver progenitor cells in liver cancer initiation

Researchers receive DoD grant to target chemotherapy resistance in pancreatic cancer

New small molecule drug targets active state of cancer-causing KRAS mutant

Bioengineered nanovesicles could improve cancer treatment

Study finds inverse correlation between dietary magnesium intake and peripheral arterial disease

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News